| P50 | author | Zbyszek Darzynkiewicz | Q33103772 |
| | Sophie Chen | Q45323024 |
| | Frank Traganos | Q77609899 |
| P2093 | author name string | Jian Gao | |
| | H Dorota Halicka | |
| P2860 | cites work | NF-kappaB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells | Q24336679 |
| | Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population | Q28195592 |
| | Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model | Q28210937 |
| | NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon? | Q28235522 |
| | Molecular determinants of resistance to antiandrogen therapy | Q28236889 |
| | Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action | Q33232382 |
| | Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells. | Q33235488 |
| | Oridonin inhibits cell growth by induction of apoptosis on human hepatocelluar carcinoma BEL-7402 cells | Q33241115 |
| | Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer | Q33650205 |
| | Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. | Q33960065 |
| | Chinese herbal mixture PC SPES in treatment of prostate cancer (review). | Q34038207 |
| | Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer. | Q34338135 |
| | PC-SPES: herbal formulation for prostate cancer | Q34914418 |
| | Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells | Q35221988 |
| | Androgen receptor decoy molecules block the growth of prostate cancer | Q35611734 |
| | The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathways | Q36126920 |
| | Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: potential therapeutic approaches for prostate cancer. | Q36207417 |
| | Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis | Q36309725 |
| | Mechanisms leading to the development of hormone-resistant prostate cancer | Q36456488 |
| | Drug insight: role of the androgen receptor in the development and progression of prostate cancer | Q36773464 |
| | Inappropriate activation of the androgen receptor by nonsteroids: involvement of the Src kinase pathway and its therapeutic implications | Q38307975 |
| | Androgens regulate the immune/inflammatory response and cell survival pathways in rat ventral prostate epithelial cells | Q38320457 |
| | Cyclooxygenase-2 (COX-2) expression is an independent predictor of prostate cancer recurrence | Q38438329 |
| | Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells | Q40132800 |
| | Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cells | Q40135223 |
| | Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells | Q40218951 |
| | Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells | Q40251128 |
| | Androgen-dependent regulation of Her-2/neu in prostate cancer cells | Q40272793 |
| | Evolution of the androgen receptor pathway during progression of prostate cancer. | Q40278784 |
| | Polyphenols purified from the Brazilian aroeira plant (Schinus terebinthifolius, Raddi) induce apoptotic and autophagic cell death of DU145 cells. | Q40316961 |
| | Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations | Q40342379 |
| | Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways | Q40435902 |
| | Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells. | Q40464312 |
| | Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells. | Q40475869 |
| | Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. | Q40636149 |
| | Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest | Q40762945 |
| | Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients | Q40921601 |
| | Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES. | Q41101601 |
| | PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo . | Q41714789 |
| | In vitro mechanism of PC SPES. | Q43705356 |
| | Effects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines | Q43759636 |
| | In vivo effect of PC-SPES on prostate growth and hepatic CYP3A expression in rats | Q44391274 |
| | The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage. | Q45259728 |
| | Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer | Q46117080 |
| | Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824. | Q46709554 |
| | Skullcapflavone I from Scutellaria baicalensis induces apoptosis in activated rat hepatic stellate cells | Q46736843 |
| | Arachidonic acid activates phosphatidylinositol 3-kinase signaling and induces gene expression in prostate cancer | Q46923183 |
| | Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. | Q47938173 |
| | Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition. | Q52548183 |
| | Blockade of cytokine-induced endothelial cell adhesion molecule expression by licorice isoliquiritigenin through NF-kappaB signal disruption. | Q52576601 |
| | RNA interference-mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor. | Q53345643 |
| | Androgen receptor outwits prostate cancer drugs. | Q53907010 |
| | Regulation of I B Kinase Expression by the Androgen Receptor and the Nuclear Factor- B Transcription Factor in Prostate Cancer | Q58325218 |
| | Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer | Q60156355 |
| | Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer | Q77300267 |
| | Wogonin suppresses TNF-alpha-induced MMP-9 expression by blocking the NF-kappaB activation via MAPK signaling pathways in human aortic smooth muscle cells | Q79277670 |
| | Effects of wogonin on the levels of cytokines and functions of leukocytes associated with NF-kappa B expression in Sprague-Dawley rats | Q80090555 |
| | Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer | Q80352321 |
| | American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer | Q81725224 |
| P433 | issue | 2 | |
| P921 | main subject | phytochemistry | Q640068 |
| P304 | page(s) | 405-411 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | International Journal of Oncology | Q6051527 |
| P1476 | title | Down-regulation of androgen-receptor and PSA by phytochemicals | |
| P478 | volume | 32 | |